Chunxu Xue

Dr. Chunxu Xue


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
CXChunxu Xue
Chunxu Xue
JLJiwen Liu
Jiwen Liu
David Lea-SmithDavid Lea-Smith
David Lea-Smith
GRGary Rowley
Gary Rowley
HLHeyu Lin
Heyu Lin
XZXiao-Hua Zhang
Xiao-Hua Zhang
The Earth’s oceans are a huge body of water with physicochemical properties and microbial community profiles that change with depth, which in turn influences their biogeochemical cycling potential. The differences between microbial communities and their functional potential in surface to hadopelagic water samples are only beginning to be explored. Here, we used metagenomics to investigate the microbial communities and their potential to drive biogeochemical cycling in seven different water layers down the vertical profile of the Challenger Deep (0–10,500 m) in the Mariana Trench, the deepest natural point in the Earth’s oceans. We recovered 726 metagenome-assembled genomes (MAGs) affiliated to 27 phyla. Overall, biodiversity increased in line with increased depth. In addition, the genome size of MAGs at ≥4000 m layers was slightly larger compared to those at 0–2000 m. As expected, surface waters were the main source of primary production, predominantly from Cyanobacteria. Intriguingly, microbes conducting an unusual form of nitrogen metabolism were identified in the deepest waters (>10,000 m), as demonstrated by an enrichment of genes encoding proteins involved in dissimilatory nitrate to ammonia conversion (DNRA), nitrogen fixation and urea transport. These likely facilitate the survival of ammonia-oxidizing archaea α lineage, which are typically present in environments with a high ammonia concentration. In addition, the microbial potential for oxidative phosphorylation and the glyoxylate shunt was enhanced in >10,000 m waters. This study provides novel insights into how microbial communities and their genetic potential for biogeochemical cycling differs through the Challenger deep water column, and into the unique adaptive lifestyle of microbes in the Earth’s deepest seawater.

8 October 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
XCXiulei Cai
Xiulei Cai
MYMin Yu
Min Yu
HSHu Shan
Hu Shan
XTXiaorong Tian
Xiaorong Tian
YZYanfen Zheng
Yanfen Zheng
XZXiao-Hua Zhang
Xiao-Hua Zhang
Gram-negative bacteria utilize N-acylhomoserine lactones (AHLs) as quorum sensing (QS) signaling molecules for intercellular communication. Cell-to-cell communication depends on cell population density, and AHL-dependent QS is related to the production of multiple genes including virulence factors. Quorum quenching (QQ), signal inactivation by enzymatic degradation, is a potential strategy for attenuating QS regulated bacterial infections. Both Gram-positive and -negative bacteria have QQ enzymes that can degrade AHLs. In our previous study, strain Ruegeria mobilis YJ3, isolated from healthy shrimp, showed strong AHLs degradative activity. In the current study, an AHL lactonase (designated RmmL) was cloned and characterized from Ruegeria mobilis YJ3. Amino acid sequence analysis showed that RmmL has a conserved “HXHXDH” motif and clusters together with lactonase AidC that belongs to the metallo-β-lactamase superfamily. Recombinant RmmL could degrade either short- or long-chain AHLs in vitro. High-performance liquid chromatography analysis indicated that RmmL works as an AHL lactonase catalyzing AHL ring-opening by hydrolyzing lactones. Furthermore, RmmL can reduce the production of pyocyanin by Pseudomonas aeruginosa PAO1, while for the violacein and the extracellular protease activities by Chromobacterium violaceum CV026 and Vibrio anguillarum VIB72, no significant reduction was observed. This study suggests that RmmL might be used as a therapeutic agent in aquaculture.

11 November 2025 in Foods
Verified
Journal Article
Open access
PDF file
SLShuyu Li
Shuyu Li
YLYanhui Li
Yanhui Li
CXChunxu Xue
Chunxu Xue
YZYing Zhang
Ying Zhang
TTTong Tong
Tong Tong
HSHaiyan Sun
Haiyan Sun
Sleep disorders represent a growing global health concern with significant socio-economic impacts. GABA, a natural bioactive compound abundant in various fermented foods, especially probiotic-fermented foods, has garnered increasing attention for its potential to improve sleep quality. This review systematically elucidates the multi-pathway mechanisms by which GABA regulates sleep, focusing on (1) indirect modulation of central sleep–wake circuits via the gut–brain axis through vagal nerve, neuroendocrine, and immune pathways; (2) potential entry into the brain by leveraging the dynamic permeability of the blood–brain barrier (BBB) and transporter-mediated active transport; and (3) metabolic conversion into active substances like γ-hydroxybutyrate (GHB), which synergistically optimizes sleep architecture via multiple receptor systems and energy metabolism. Furthermore, we summarize the sleep-promoting effects of GABA-enriched foods observed in animal and clinical studies and discuss emerging applications, including high-GABA-yielding probiotics and personalized nutrition strategies for sleep intervention. This review provides a theoretical basis and innovative directions for the development of GABA-based functional foods and sleep health management.

27 April 2026 in Foods
Verified
Journal Article
Open access
PDF file
ZXZhengyang Xu
Zhengyang Xu
孙孙孙子涵 孙
孙子涵 孙
FWFeiyang Wang
Feiyang Wang
QHQingyang Han
Qingyang Han
SLShuyu Li
Shuyu Li
HSHaiyan Sun
Haiyan Sun
Limosilactobacillus fermentum SHY0006 was isolated from Miao sour soup, a traditional fermented food from Guizhou, China, and systematically evaluated for its safety, metabolic functionality, and stress adaptability using phenotypic assays combined with whole-genome sequencing. SHY0006 exhibited no hemolytic activity and harbored no detectable virulence-associated or acquired antibiotic resistance genes, supporting its safety profile. Functionally, SHY0006 improved lipid metabolism and insulin resistance in both cell and animal models. In hyperlipidemic mice, hepatic triglyceride accumulation was markedly reduced, accompanied by favorable modulation of serum lipid parameters, including LDL-C, HDL-C, and free fatty acids. In diabetic mice, the strain improved insulin tolerance test (ITT) performance, indicating enhanced systemic insulin sensitivity. Whole-genome analysis revealed complete biosynthetic pathways for riboflavin and folate, along with extensive carbohydrate utilization capacity, highlighting its metabolic versatility. In addition, SHY0006 exhibited strong tolerance to environmental stress, supporting its potential viability in food matrices and gastrointestinal conditions. Collectively, these findings suggest that SHY0006 is a safe and metabolically versatile probiotic candidate with potential applications in functional foods targeting metabolic health.

19 October 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
ZRZhaoxu Ren
Zhaoxu Ren
SXShiqi Xiao
Shiqi Xiao
ZZZixin Zhang
Zixin Zhang
FWFeiyang Wang
Feiyang Wang
QKQingfang Kong
Qingfang Kong
HSHaiyan Sun
Haiyan Sun
Helicobacter pylori (H. pylori) infection is a major global gastrointestinal health concern, and increasing antibiotic resistance has prompted interest in complementary probiotic strategies. In this study, Lactiplantibacillus plantarum SHY0008 isolated from Miao sour soup was evaluated using integrated in vitro, AGS cell, zebrafish, murine, and genomic approaches. SHY0008 showed favorable gastrointestinal tolerance, with an acid survival rate of 39.61 ± 1.87% after 4 h under simulated gastric conditions and a relative viable recovery of 64.20 ± 6.48% after 4 h of exposure to 0.3% oxgall. SHY0008 also produced inhibition zones of 17.56 ± 0.58 mm and 17.21 ± 0.29 mm for viable and heat-treated/sonicated bacterial preparations, respectively, and reduced the H. pylori urease-associated phenol-red response by 54.23 ± 3.98%. In AGS cells, SHY0008 showed an adhesion rate of 17.53 ± 1.01% and reduced the urease-associated H. pylori adhesion signal by 48.27 ± 2.52%. In a prophylactic zebrafish model, SHY0008 pretreatment was associated with reduced intestinal H. pylori-associated fluorescence and histopathological injury following subsequent exposure. In mice, SHY0008 reduced gastric H. pylori-associated antigen and urease signals, lowered serum CXCL1/KC, and improved gastric histopathology. Whole-genome analysis identified plantaricin-associated genes, while preliminary genome-based safety screening detected no known acquired antimicrobial resistance genes or virulence-associated determinants. Collectively, these findings support SHY0008 as a promising food-derived probiotic candidate with complementary anti-H. pylori and gastroprotective activities.